Academic Hematopathologist / Molecular Pathologist

Academic Hematopathologist / Molecular Pathologist Mid-Career / Senior Academic Clinician or Physician-Scientist Department of Pathology Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, Inc. Harvard Medical School, Boston The Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) is recruiting a full-time mid-career to senior academic hematopathologist. BIDMC is a tertiary care facility with 743 licensed beds and is an internationally renowned teaching hospital affiliated with Harvard Medical School. It is also associated with an NCI Comprehensive Cancer Center, with a strong and growing focus on hematologic malignancies. The BIDMC Department of Pathology has launched strategic initiatives in cutting-edge Precision Diagnostics, including cancer genomics, multiplex biomarker theranostics, and computational/digital pathology. Additionally, the department is engaged in a new clinical collaboration between Dana-Farber Cancer Institute, BIDMC, and Harvard Medical Faculty Physicians to establish New England's only free-standing adult inpatient cancer hospital. This collaboration aims to bring together world-class clinicians to deliver transformational, precision medicine dedicated to defying cancer. We seek an active, energetic, team-oriented faculty member to help shape our future agenda and take leadership in developing these initiatives. Candidates should possess strong hematopathology diagnostic skills, with expertise in advanced flow cytometry and molecular diagnostics (including NGS and FISH). A strong interest in developing the role of Pathology in clinical trials, including new companion diagnostics, is desirable. Applicants with a robust clinical, translational, or laboratory-based research program are encouraged to apply. Candidates with existing NIH grant funding will be supported with research space and start-up funds to expand their programs. The successful candidate will join a team of hematopathologists, cytogeneticists, molecular diagnosticians, residents, and fellows, providing diagnostics for benign and malignant hematology, stem cell transplantation, and the cancer vaccine and T-cell therapies center at BIDMC. Applicants must be board certified in Pathology (AP or AP/CP) and Hematopathology. Board certification in Molecular Pathology, including NGS experience, is a significant plus. The candidate will be appointed as a full-time faculty member of Harvard Medical School at an academic rank appropriate to their experience. Research: BIDMC ranks as a national leader among independent hospitals in NIH funding, with over $229.8 million annually. Researchers at BIDMC manage more than 850 active sponsored projects and 500 clinical trials, funded and non-funded. The Harvard-Thorndike Laboratory, the nation's oldest clinical research laboratory, has been located on this site since 1973. BIDMC shares clinical and research programs with institutions such as the Dana-Farber / Harvard Cancer Center, Joslin Diabetes Center, and Children's Hospital. BIDMC is part of Beth Israel Lahey Health, a system that unites academic medical centers, teaching hospitals, community and specialty hospitals, and 38,000 employees dedicated to expanding access to care and advancing medical science through research and education. Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP) is one of the largest physician organizations in New England, committed to excellence and innovation in patient care, education, and research. As a physician-led organization, HMFP partners with over 2,200 providers to support exceptional care, professional development, diversity, and work-life balance. HMFP physicians hold faculty appointments at Harvard Medical School and provide care across the Beth Israel Lahey Health system and other hospitals in Massachusetts. Beth Israel Deaconess Medical Center is committed to increasing diversity and encourages applications from women and underrepresented minorities. #J-18808-Ljbffr